ALERT: COVID19 Update: For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patient’s protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine visits are available for routine office visits.

All Patients – Very Important: Regardless of vaccination status.  If you are experiencing a fever or cold-like like symptoms, which also include GI Symptoms and Diarrhea, you should contact your Virginia Cancer Specialists Advice Line before visiting our clinics for scheduled appointments. This includes symptoms of respiratory illness, such as coughing or difficulty breathing.  More Information-PLEASE CLICK HERE

Archive

Post Archive: Felasfa M. Wodajo MD

ASCO Approves the First Joint MSTS/ASTRO/ASCO Guideline on the Treatment of Metastatic Carcinoma and Myeloma of the Femur - Felasfa M. Wodajo, MD

February 26, 2021
Read More

Felasfa Wodajo, MD - Treatment of Metastatic Carcinoma and Myeloma of the Femur: Joint MSTS/ASTRO/ASCO Guideline

October 2, 2020
Read More

Felasfa Wodajo MD, Surgeon Virginia Cancer Specialists helps a patient with a rare condition. Washington Post

February 24, 2020
Read More

Sarcoma Awareness Month July 2019

July 30, 2019
Read More

3D Printing in Orthopaedic Surgery, Felasfa M. Wodajo, M.D. Musculoskeletal Tumor Surgeon Sarcoma Center

April 16, 2019
Read More

An Osteosarcoma survivor tells his amazing story for the Virginia Cancer Specialists annual Sarcoma Survivor's Event.

October 15, 2018
Read More

Trial Underway for Checkpoint Blockade in Soft Tissue Sarcoma - Felafsa Wodajo, MD

October 8, 2018
Read More

Sarcoma Survivor’s Dinner Wednesday September 12, 2018

August 30, 2018
Read More

Important News for Patients with Sarcoma in the DC Metro Region - 3-D Printing rapidly becoming a useful tool

July 9, 2018
Read More